Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Denise Vodegel

1PUBLICATIONS

15CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Apr 02, 2021

Clinically applicable CD34<sup>+</sup>-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses.

Jesper van Eck van der Sluijs, Diede van Ens, Soley Thordardottir

Pageof 1

Frequent Collaborators

1 joint publications

Jesper van Eck van der Sluijs

1 joint publications

Diede van Ens

1 joint publications

Soley Thordardottir

1 joint publications

Inge Hermens

1 joint publications

Anniek B van der Waart

1 joint publications

J H Frederik Falkenburg

1 joint publications

Michel G D Kester

1 joint publications

Iris de Rink

1 joint publications

Mirjam H M Heemskerk

1 joint publications

Jannie Borst

Frequent Collaborators

1 joint publications

Jesper van Eck van der Sluijs

1 joint publications

Diede van Ens

1 joint publications

Soley Thordardottir

1 joint publications

Inge Hermens

Top Related Videos

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on : Aug 01, 2025

See more related videos

Top Related Videos

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on : Aug 01, 2025

See more related videos